{
    "organizations": [],
    "uuid": "704850aed4999f7f2fd2f59c5d2a1003525ff86f",
    "author": "",
    "url": "https://www.reuters.com/article/brief-covance-forms-immunology-immunotox/brief-covance-forms-immunology-immunotoxicology-unit-focused-on-biologic-drug-development-idUSFWN1QR0G5",
    "ord_in_thread": 0,
    "title": "BRIEF-Covance Forms Immunology & Immunotoxicology Unit Focused On Biologic Drug Development",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 9 (Reuters) - Laboratory Corporation Of America Holdings:\n* COVANCE FORMS IMMUNOLOGY & IMMUNOTOXICOLOGY UNIT FOCUSED ON BIOLOGIC DRUG DEVELOPMENT\n* LABCORP - COVANCE DRUG DEVELOPMENT BUSINESS HAS FORMED A GLOBAL IMMUNOLOGY AND IMMUNOTOXICOLOGY UNIT Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-09T15:47:00.000+02:00",
    "crawled": "2018-03-09T15:53:46.020+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "laboratory",
        "corporation",
        "america",
        "holding",
        "covance",
        "form",
        "immunology",
        "immunotoxicology",
        "unit",
        "focused",
        "biologic",
        "drug",
        "development",
        "labcorp",
        "covance",
        "drug",
        "development",
        "business",
        "formed",
        "global",
        "immunology",
        "immunotoxicology",
        "unit",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}